DNTH
Price
$36.71
Change
+$0.87 (+2.43%)
Updated
Sep 26 closing price
Capitalization
1.46B
TRML
Price
$47.74
Change
+$0.02 (+0.04%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.23B
Interact to see
Advertisement

DNTH vs TRML

Header iconDNTH vs TRML Comparison
Open Charts DNTH vs TRMLBanner chart's image
Dianthus Therapeutics
Price$36.71
Change+$0.87 (+2.43%)
Volume$936.07K
Capitalization1.46B
Tourmaline Bio
Price$47.74
Change+$0.02 (+0.04%)
Volume$12.38K
Capitalization1.23B
DNTH vs TRML Comparison Chart in %
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. TRML commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a StrongBuy and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (DNTH: $36.71 vs. TRML: $47.74)
Brand notoriety: DNTH and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 80% vs. TRML: 37%
Market capitalization -- DNTH: $1.43B vs. TRML: $1.23B
DNTH [@Biotechnology] is valued at $1.43B. TRML’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than TRML.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 3 TA indicator(s) are bullish while TRML’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 3 bullish, 6 bearish.
  • TRML’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TRML is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а -0.11% price change this week, while TRML (@Biotechnology) price change was +0.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($1.46B) has a higher market cap than TRML($1.23B). TRML YTD gains are higher at: 135.404 vs. DNTH (68.394). TRML has higher annual earnings (EBITDA): -102.41M vs. DNTH (-129.49M). DNTH has more cash in the bank: 257M vs. TRML (239M). TRML has less debt than DNTH: TRML (145K) vs DNTH (1.33M). DNTH has higher revenues than TRML: DNTH (4.85M) vs TRML (0).
DNTHTRMLDNTH / TRML
Capitalization1.46B1.23B119%
EBITDA-129.49M-102.41M126%
Gain YTD68.394135.40451%
P/E Ratio3.24N/A-
Revenue4.85M0-
Total Cash257M239M108%
Total Debt1.33M145K917%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHTRML
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 5 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFTMX22.44N/A
N/A
Fidelity Advisor Asset Manager 50% M
LIFEX17.22N/A
N/A
Domini Sustainable Solutions Ins
BFTIX67.20N/A
N/A
Baron Fifth Avenue Growth Instl
FIMPX38.90N/A
N/A
Nuveen Small Cap Growth Opp I
KTCIX55.46N/A
N/A
DWS Science and Technology Inst

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with XNCR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+2.43%
XNCR - DNTH
48%
Loosely correlated
+12.00%
CRNX - DNTH
48%
Loosely correlated
+27.92%
IMNM - DNTH
45%
Loosely correlated
+14.13%
OCUL - DNTH
45%
Loosely correlated
+2.33%
ERAS - DNTH
44%
Loosely correlated
+14.92%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been loosely correlated with DNTH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TRML jumps, then DNTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+0.04%
DNTH - TRML
42%
Loosely correlated
+2.43%
CRNX - TRML
38%
Loosely correlated
+27.92%
STOK - TRML
36%
Loosely correlated
+5.23%
ARVN - TRML
35%
Loosely correlated
+6.58%
VRDN - TRML
34%
Loosely correlated
+5.77%
More